Watch Ticker

Mannkind Corporation

Go to Mannkind Corporation Website

$4.26

(%)
Live
Previous Close

$4.26

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.1 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

MANNKIND ANNOUNCES IND CLEARANCE FROM U.S. FDA TO START PHASE 3 STUDY OF CLOFAZIMINE INHALATION SUSPENSION FOR NTM LUNG DISEASE

Related tickers: MNKD.

Read Full Article

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 03, 2024 (GLOBE NEWSWIRE) --  MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has repaid in full all outstanding indebtedness under both its credit and security agreement with MidCap Financial Trust (the “Loan Agreement”) and its convertible promissory note issued to Mann Group LLC (the “Note”).

Related tickers: MNKD.

Read Full Article
Trending Tickers
DATS

XNAS

$1.25
(%)
LASE

XNAS

$2.05
(%)
NYCB

XNYS

$2.79
(%)
PACW

XNAS

$0.00
(%)
MLGO

XNAS

$0.00
(%)